We review the history of antenatal corticosteroid therapy (ACS) and present recent
experimental data to demonstrate that this, one of the pillars of perinatal care, has been …

Abstract Treatment with antenatal corticosteroids (ACS) is standard of care for women at risk
of preterm birth between 24 and 34 weeks' gestation. ACS are increasingly used for other …

Antenatal corticosteroids have been proven to accelerate fetal lung development and
reduce neonatal morbidity and mortality when given between 28 and 34 weeks of gestation …

Corticosteroid treatment of pregnant women at risk for preterm delivery enhances fetal lung
maturity and improves neonatal outcomes.'Despite convincing evidence of these effects, a …

Background Antenatal corticosteroids are among the most important and widely used
interventions to improve outcomes for preterm infants. Antenatal corticosteroid dosing …

Physicians caring for pregnant women and their preterm infants have used corticosteroids
since Liggins and Howie reported in 1972 that prenatal betamethasone decreased the …

The practice of antenatal corticosteroid administration in pregnancies of 24–34 weeks of
gestation that are at risk of preterm delivery was adopted over 20 years after the first …

Antenatal corticosteroids (ANS) are the major intervention to decrease respiratory distress
syndrome and mortality from premature birth and are standard of care. The use of ANS is …

Antenatal corticosteroids (ACS) successfully reduce the rates of neonatal mortality and
morbidity after preterm birth. However, this translational success story is not without …

Preterm birth occurs in approximately 10% of all births, and accounts for 75% of neonatal
deaths not associated with congenital malformations. The administration of antenatal …